300406: Beijing Strong Biotechnologies,Inc. - Summary | Jitta

Beijing Strong Biotechnologies,Inc.

CHN:300406

Price
CN¥12.70
Loss Chance
47.5%
5.50JITTA SCORE
147.12%Over Jitta Line
Jitta Ranking
112 / 487
1,093 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (45)
Recent Business Performance (29)
Financial Strength (80)
Return to Shareholders (49)
Competitive Advantage (39)
Jitta Signs
Debt LevelLow Long Term Debt
CapExVery Low
Revenue and EarningRevenue decline from 2022-2025
Recent Business PerformanceEarning decline 41.46% in the last year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.50
147.12%
3.56
958.46%
4.24
> 1,000%
Biotechnology
4.53
53.96%
7.72
18.96%
5.58
85.23%
COMPANY DESCRIPTION
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein S activity, protein C, lupus anticoagulant, fibrin degradation products, and d-dimer. It also provides blood grouping card comprising ABO blood type anti stereotype detection card, DiaClon ABD-confirmation, and DiaClon ABO/D+ reverse grouping for patients; and automatic coagulation analyzer, automatic biochemistry analyzer, fully automatic chemiluminescence immunoassay analyzer, and automated blood groupings analyzer. In addition, the company provides technology and document services. It sells its products under the GCELL and Beijing MDC brands. The company was founded in 2001 and is based in Beijing, China.